Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32813759)

  • 1. PPARG expression in colorectal cancer and its association with staging and clinical evolution.
    Villa ALP; Parra RS; Feitosa MR; Camargo HP; Machado VF; Tirapelli DPDC; Rocha JJRD; Feres O
    Acta Cir Bras; 2020; 35(7):e202000708. PubMed ID: 32813759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.
    Sabatino L; Fucci A; Pancione M; Carafa V; Nebbioso A; Pistore C; Babbio F; Votino C; Laudanna C; Ceccarelli M; Altucci L; Bonapace IM; Colantuoni V
    Oncogene; 2012 Dec; 31(49):5061-72. PubMed ID: 22286757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression of nuclear factor of activated T-cells, cytoplasmic 2 (NFATc2) and peroxisome proliferator-activated receptor gamma (PPARG) transcription factors in colorectal carcinoma.
    Zafari V; Hashemzadeh S; Hosseinpour Feizi M; Pouladi N; Rostami Zadeh L; Sakhinia E
    Bosn J Basic Med Sci; 2017 Aug; 17(3):255-261. PubMed ID: 28504924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
    Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
    Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor γ coactivator-1α is a predictor of lymph node metastasis and poor prognosis in human colorectal cancer.
    Yun SH; Roh MS; Jeong JS; Park JI
    Ann Diagn Pathol; 2018 Apr; 33():11-16. PubMed ID: 29566941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CORR® ORS Richard A. Brand Award: Disruption in Peroxisome Proliferator-Activated Receptor-γ (PPARG) Increases Osteonecrosis Risk Through Genetic Variance and Pharmacologic Modulation.
    Wyles CC; Paradise CR; Houdek MT; Slager SL; Terzic A; Behfar A; van Wijnen AJ; Sierra RJ
    Clin Orthop Relat Res; 2019 Aug; 477(8):1800-1812. PubMed ID: 31135556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction.
    Mallon PW; Sedwell R; Rogers G; Nolan D; Unemori P; Hoy J; Samaras K; Kelleher A; Emery S; Cooper DA; Carr A;
    J Infect Dis; 2008 Dec; 198(12):1794-803. PubMed ID: 18954260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin and peroxisome proliferator-activated receptor γ expression in colorectal adenoma.
    Kim HH; Kim YS; Kang YK; Moon JS
    World J Gastroenterol; 2012 Feb; 18(6):557-62. PubMed ID: 22363123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the metastasis suppressor gene KiSS1 is associated with lymph node metastasis and poor prognosis in human colorectal cancer.
    Okugawa Y; Inoue Y; Tanaka K; Toiyama Y; Shimura T; Okigami M; Kawamoto A; Hiro J; Saigusa S; Mohri Y; Uchida K; Kusunoki M
    Oncol Rep; 2013 Sep; 30(3):1449-54. PubMed ID: 23784200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
    Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
    Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
    Dubosq F; Ploussard G; Soliman H; Turpin E; Latil A; Desgrandchamps F; de The H; Mongiat-Artus P
    Urol Oncol; 2012; 30(6):833-40. PubMed ID: 21489836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Significance of Peroxisome Proliferator-Activated Receptor γ and TRAP220 in Patients with Operable Colorectal Cancer.
    Kwon KA; Yun J; Oh SY; Seo BG; Lee S; Lee JH; Kim SH; Choi HJ; Roh MS; Kim HJ
    Cancer Res Treat; 2016 Jan; 48(1):198-207. PubMed ID: 26130665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Wang W; Lönnroth C; Lundholm K
    Int J Cancer; 2007 Jul; 121(2):232-40. PubMed ID: 17290397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer.
    Moon CM; Kwon JH; Kim JS; Oh SH; Jin Lee K; Park JJ; Pil Hong S; Cheon JH; Kim TI; Kim WH
    Int J Cancer; 2014 Feb; 134(3):519-29. PubMed ID: 23852449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
    Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and significance of the Wip1 proto-oncogene in colorectal cancer.
    Li ZT; Zhang L; Gao XZ; Jiang XH; Sun LQ
    Asian Pac J Cancer Prev; 2013; 14(3):1975-9. PubMed ID: 23679302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.
    Al Obeed OA; Alkhayal KA; Al Sheikh A; Zubaidi AM; Vaali-Mohammed MA; Boushey R; Mckerrow JH; Abdulla MH
    World J Gastroenterol; 2014 Dec; 20(48):18390-6. PubMed ID: 25561807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.